Villanova Investment Management Co LLC Raises Stock Position in DENTSPLY SIRONA Inc. $XRAY

Villanova Investment Management Co LLC increased its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 88.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 152,913 shares of the medical instruments supplier’s stock after acquiring an additional 71,964 shares during the period. Villanova Investment Management Co LLC owned approximately 0.08% of DENTSPLY SIRONA worth $1,940,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Clearstead Advisors LLC increased its position in shares of DENTSPLY SIRONA by 210.4% in the third quarter. Clearstead Advisors LLC now owns 8,319 shares of the medical instruments supplier’s stock valued at $106,000 after buying an additional 5,639 shares in the last quarter. Michels Family Financial LLC purchased a new stake in shares of DENTSPLY SIRONA in the third quarter valued at about $489,000. Brickwood Asset Management LLP grew its position in shares of DENTSPLY SIRONA by 5,515.8% in the third quarter. Brickwood Asset Management LLP now owns 1,524,074 shares of the medical instruments supplier’s stock valued at $19,340,000 after purchasing an additional 1,496,935 shares during the last quarter. Syon Capital LLC purchased a new position in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $199,000. Finally, Rothschild Investment LLC lifted its stake in DENTSPLY SIRONA by 9,790.7% in the 3rd quarter. Rothschild Investment LLC now owns 14,836 shares of the medical instruments supplier’s stock valued at $188,000 after buying an additional 14,686 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on XRAY. Barrington Research reissued an “outperform” rating and issued a $14.00 price target on shares of DENTSPLY SIRONA in a report on Monday, January 5th. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Tuesday, December 16th. JPMorgan Chase & Co. lowered their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Friday, November 7th. Stifel Nicolaus set a $13.00 price objective on shares of DENTSPLY SIRONA in a research note on Thursday, November 6th. Finally, Zacks Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Three research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and an average target price of $14.46.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $12.54 on Monday. The company has a debt-to-equity ratio of 1.36, a quick ratio of 0.99 and a current ratio of 1.47. The firm has a market capitalization of $2.50 billion, a price-to-earnings ratio of -2.84, a price-to-earnings-growth ratio of 0.99 and a beta of 1.01. DENTSPLY SIRONA Inc. has a one year low of $9.85 and a one year high of $19.27. The company has a 50 day moving average price of $12.23 and a 200 day moving average price of $12.47.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 9th. Shareholders of record on Friday, December 26th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 5.1%. The ex-dividend date of this dividend was Friday, December 26th. DENTSPLY SIRONA’s payout ratio is -14.48%.

Insider Buying and Selling

In other news, Director Gregory T. Lucier sold 82,200 shares of the firm’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.52% of the stock is owned by corporate insiders.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.